Truist Financial’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,343
Closed -$408K 2747
2021
Q2
$408K Sell
11,343
-4,827
-30% -$178K ﹤0.01% 2195
2021
Q1
$631K Buy
16,170
+67
+0.4% +$3.01K ﹤0.01% 1849
2020
Q4
$672K Buy
+16,103
New +$740K ﹤0.01% 1712

Other funds holding GDRX

Truist Financial's GDRX Position: Q3 2021 in Review

Truist Financial sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 11,343 shares — an estimated $408K sold.

Truist Financial first reported a position in GDRX in Q4 2020 and held it in 3 quarters. The position peaked at $672K in Q4 2020. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

  • Truist Financial reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
  • Truist Financial sold 11,343 GoodRx Holdings shares in Q3 2021, an estimated $408K.
  • Truist Financial first reported a position in GoodRx Holdings in Q4 2020 and held it in 3 quarters.
  • Truist Financial's GoodRx Holdings position peaked at $672K in Q4 2020.
  • 218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on Truist Financial's 13F filing for Q3 2021, filed 5 Nov 2021.